EX-10.1
AVITA Medical, Inc.
Certain identified information (as indicated by “[***]”) has been excluded from the exhibit because it both (i) is not material and (ii) is the type that the company treats as private or confidential.
Global Amendment to the Contract Manufacturing Agreement and Exclusive Distribution Agreement
This Global Amendment to the Contract Manufacturing Agreement and Exclusive Distribution Agreement (this “Amendment”), is effective as of August 5, 2026 (the “Effective Date”), and concurrently amends the Contract Manufacturing Agreement with an Effective Date of March 17, 2025 (the “Manufacturing Agreement”) and the Exclusive Distribution Agreement with an Effective Date of January 10, 2024, subsequently amended on April 30, 2024 and March 17, 2025 (the “DistributionAgreement”, and, together with the Manufacturing Agreement, the “Existing Agreements”), each by and between AVITA Medical Americas, LLC (“AVITA Medical”, or under the Manufacturing Agreement, the “Seller”, and under the Distribution Agreement, the “Distributor”) and Stedical Scientific, Inc. (“Stedical”, or under the Manufact
…